
Can cancer drugs treat Alzheimer's? New study thinks so
As per Alzheimer's Association, in 2025, global Alzheimer's statistics indicate a significant prevalence of the disease, with projections estimating that over 7 million Americans will be living with Alzheimer's dementia. Globally, it is estimated that someone develops dementia every three seconds, and the number of people living with dementia is expected to reach 78 million by 2030.
The progressive neurodegenerative disorder, long considered a therapeutic dead end, may soon find some hope of cure in an unlikely ally: cancer drugs.
Recent research reveals that several oncology medications, originally designed to fight tumors, have shown promise in targeting key pathways of Alzheimer's disease (AD), from protein aggregation to neuroinflammation and metabolic dysfunction.
Let's delve deeper into the newest discovery of the silver lining.
The medical breakthrough:
Scientists are exploring cancer drugs as a potential way to tackle Alzheimer's disease, given that the options for treatment are quite limited.
As cases of Alzheimer's continue to rise in the U.S. and around the world due to an aging population, there still isn't a cure. Efforts to create new treatments that actually slow the disease's progression have mostly fallen short.
Currently, only two drugs, Leqembi and Kisunla, are approved by the FDA to slow down early Alzheimer's, but their effectiveness is very limited. Many pharmaceutical companies have even stopped developing Alzheimer's drugs after unsuccessful trials, while others are experimenting with existing medications, including popular weight loss drugs.
Researchers at the University of California, San Francisco, have taken a different approach. They searched through a database of over 1,300 various drugs, like antipsychotics and chemotherapy drugs, to find ones that could be repurposed for Alzheimer's treatment. Their study, published in the journal
Cell
, highlighted two cancer drugs that showed promise in reducing Alzheimer's risk. When tested together on mice, these drugs appeared to slow or even reverse Alzheimer's symptoms.
One drug is typically used for breast cancer, and the other works against colon and lung cancer. Alzheimer's is known to cause significant changes in gene expression in the brain, which can disrupt brain function and lead to memory loss.
From their database, fewer than 90 drugs successfully reversed markers related to Alzheimer's in human brain cells. Of these, five drugs seemed particularly effective in lowering Alzheimer's risk for actual patients, and the researchers focused on two FDA-approved cancer drugs to test in mice.
According to the findings, letrozole, a breast cancer drug, appeared to influence gene expression in nerve cells, while irinotecan, used for colon and lung cancer, affected glial cells, which support the nervous system. Alzheimer's can damage nerve cells and trigger an overgrowth of glial cells, leading to brain inflammation.
Interestingly, past studies have shown that breast cancer patients on letrozole had a lower chance of developing Alzheimer's, and colorectal cancer survivors treated with irinotecan also showed decreased risk, adding to the excitement around these findings.
The groundbreaking findings:
Researchers have been testing a combination of two cancer drugs in mice and found some promising results: the combo reversed brain degeneration and improved memory in mice showing signs of Alzheimer's. However, because what works in mice doesn't always work in humans, they plan to test these drugs in a clinical trial with Alzheimer's patients.
Dr. Yadong Huang, a co-author of the study and a neurology professor at UCSF, noted the advantages of repurposing existing drugs: 'Developing a new drug can take hundreds of millions, or even billions, of dollars, and on average takes more than 10 years.
For this repurposed drug, usually, it just takes two or three years, and then you can go to the clinical trial, and the cost is much, much lower.' Despite this progress, he acknowledged, as reported by NBC News, 'We still haven't generated or produced any very effective drugs that can really slow down dramatically the cognitive decline.
'
Alzheimer's remains a complex disease, and its exact cause is still a mystery. Currently, it isn't clear why these cancer drugs might help with Alzheimer's.
One idea is that the breast cancer drug reduces estrogen production, which controls many genes. Another theory is that the colon and lung cancer drug might reduce inflammation in the brain by stopping glial cells from multiplying.
Dr. Melanie McReynolds, a biochemistry assistant professor at Pennsylvania State University, who wasn't involved in this study, added another angle. Her research suggests that another cancer drug can help Alzheimer's by regulating glucose metabolism, which is how cells generate energy.
'With aging, with stress, with diseases, that line of communication is disrupted,' she explained. She believes the drug combo could reverse metabolic decline, calling it 'the secret for contributing to better outcomes with Alzheimer's.
'
What's ahead:
Cancer drug repurposing opens a transformative chapter in Alzheimer's treatment, where repurposing anticancer agents allows researchers to exploit existing toxicity and pharmacokinetic data, potentially accelerating human testing and reducing development costs.
While these findings are exciting, the potential side effects need to be carefully considered. Letrozole can cause hot flashes, and irinotecan may lead to severe diarrhea. 'These drugs have huge side effects, so you need to always balance and figure out whether those types of side effects would be amenable to somebody with Alzheimer's,' Sirota cautioned. 'It's not that it's a slam dunk.'
Reduced risk of Alzheimer's disease linked to target protein for diabetes, as per a study
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hindustan Times
30 minutes ago
- Hindustan Times
Walking daily may protect your brain from Alzheimer's, reveals 10-year study
If you've been looking for a reason to lace up your shoes and hit the pavement, a recent long-term study may be the motivation you need. Walking daily has been linked to a reduced risk of cognitive decline, especially for those with a genetic predisposition to Alzheimer's disease. The effects of walking extend beyond mere physical exercise; they also have a positive impact on brain health(Unsplash) The findings are based on a comprehensive study published in the journal JAMA and presented at the Alzheimer's Association International Conference, which tracked nearly 3,000 participants aged 70 to 79 over the years. Researchers noted their daily walking habits and found that maintaining or increasing these habits led to improved processing speed and executive function, key aspects of cognitive health. Dr Cindy Barha, the study's lead author and an assistant professor at the University of Calgary, emphasised the importance of combating sedentary behaviour. She suggests incorporating short walking sessions throughout the day to break up long periods of sitting. What is Alzheimer's disease? Alzheimer's disease is a complex disorder that represents a severe form of dementia. It is characterised by the accumulation of harmful plaques in the brain, which disrupt communication between nerve cells and eventually lead to their death. As nerve cells deteriorate, individuals may encounter: Memory loss: Difficulty recalling recent events or personal experiences. Difficulty recalling recent events or personal experiences. Confusion: Disorientation, especially in familiar environments. Disorientation, especially in familiar environments. Personality changes: Noticeable shifts in behaviour or mood. Unfortunately, there is currently no cure for Alzheimer's, making prevention strategies increasingly important. What is the role of genetics in Alzheimer's disease? Genetic factors play a significant role in one's likelihood of developing Alzheimer's. "Notably, a gene variant known as APOE4 can make it more challenging for the brain to remove the plaques associated with the disease. Approximately 15% to 25% of the population carries this variant, which can only be identified through genetic testing," neurologist Dr Neha Kapoor tells Health Shots. How does Alzheimer's affect the mind and body? While the study didn't prescribe a specific walking routine, Dr Barha proposed that breaking up periods of inactivity with multiple short walks throughout the day can greatly benefit cognitive health. Walking recommendations Frequency: Aim for multiple short walking sessions throughout the day. Aim for multiple short walking sessions throughout the day. Consistency: Maintain a steady walking habit from year to year. Maintain a steady walking habit from year to year. Goal: A previous study published in JAMA Neurology suggested that walking approximately 3,800 steps per day can reduce the risk of dementia by 25%. Also read: Walking 7,000 steps is good enough, says new study What happens to the brain during Alzheimer's? The effects of walking extend beyond mere physical exercise. They also have a positive impact on brain health. Here are a couple of theories explaining how regular physical activity may promote cognitive function: Increased BDNF production: Exercise boosts the production of brain-derived neurotrophic factor (BDNF), a protein crucial for neuronal growth and connectivity. Dr Barha explains that muscular activity seems to release proteins that travel to the brain, enhancing BDNF levels. Exercise boosts the production of brain-derived neurotrophic factor (BDNF), a protein crucial for neuronal growth and connectivity. Dr Barha explains that muscular activity seems to release proteins that travel to the brain, enhancing BDNF levels. Reduction in neuroinflammation: 'Physical activity may also mitigate neuroinflammation, a common issue in Alzheimer's patients. The brain dispatches immune cells called microglia to clear away plaque, but chronic inflammation can lead them to attack healthy cells as well. Regular exercise can improve the functioning of these microglia,' shares Dr Kapoor. Every step truly counts. Dr Christiane Wrann, another expert associated with the study, highlighted that it's never too late to begin an exercise routine. Whether you're a seasoned walker or a newcomer, the key takeaway is to find an activity you enjoy and stick to it. Tips for getting started:


Time of India
an hour ago
- Time of India
Can a brain scan predict your death? Scientists say it might be possible and even hint diseases you could face
A quick MRI brain scan in your 40s might reveal more than just brain health; it could also predict how long you might live. According to researchers at Duke University, changes in the brain's structure can reveal how quickly your body is biologically ageing, even before symptoms of age-related diseases appear. Tired of too many ads? go ad free now This breakthrough could help doctors predict cognitive decline, chronic illnesses, and even early signs of dementia. The study highlights the role of advanced tools like DunedinPACE, which can analyse brain tissue changes and ageing patterns, paving the way for early detection and preventative healthcare strategies for longer, healthier lives. How MRI scans reveal your true biological age and future health risks Biological ageing refers to the rate at which your body is deteriorating compared to your chronological age. Two people may both be 45 years old, yet one might have a biologically younger brain and body. The Duke research revealed that those aging biologically faster had brain patterns typically seen in older adults, including tissue shrinkage and fluid buildup. These structural changes are often linked to memory decline, slower thinking, and increased risk of chronic diseases like Alzheimer's, stroke, and heart conditions. A single MRI brain scan during your 40s can now estimate your biological age and predict health risks decades in advance. Detecting faster brain aging early could transform preventative healthcare, allowing people to slow down age-related decline before it becomes irreversible. For individuals concerned about memory, dementia, or overall longevity, brain imaging could soon become as essential as routine blood tests. Tired of too many ads? go ad free now How brain scans reveal your pace of ageing The research team used an MRI-based tool called DunedinPACN, designed to calculate the Pace of Aging from a single brain scan. The system focuses on key markers like: Gray matter volume – essential for processing and cognition Cortical thickness – a sign of overall brain health Hippocampal size – critical for memory and learning Ventricle volume – an indicator of brain tissue loss These measures provide a snapshot of how the brain is holding up compared to others of the same age. What faster brain ageing means for your health. People classified as 'fast agers' had: 18% higher risk of chronic illnesses like heart disease, lung issues, and frailty within a few years 40% higher risk of early death compared to slower agers Increased likelihood of cognitive decline, memory loss, and early dementia: Interestingly, those aging slowly had brain patterns resembling much younger individuals, such as thicker cortex and larger hippocampal volumes, which are associated with better memory and healthier aging overall. How brain structure changes predict dementia risk The hippocampus plays a vital role in memory formation. A shrinking hippocampus can indicate faster aging and an increased risk of dementia. The study also noted that enlarged brain ventricles, often filled with fluid, are a sign of surrounding tissue loss—a hallmark of advanced aging. Together, these features act as biological signals of how well or poorly the brain is coping with the aging process. When applied to a separate group of adults aged 52 to 89, the DunedinPACN method showed that fast agers were 60% more likely to develop dementia later in life. These individuals also experienced cognitive decline earlier than their slow-aging counterparts. In contrast, those aging slowly had 'younger brains,' maintaining better memory and thinking skills well into their later years. Future of brain ageing research Unlike existing aging clocks, which often combine data from various age groups, this study focused exclusively on individuals in midlife, ensuring more accurate results. The ability to detect signs of accelerated aging at 40–50 years old offers an opportunity for early intervention—whether through lifestyle changes, cognitive training, or advanced therapies—to delay the onset of age-related diseases. Also Read |


Fashion Value Chain
an hour ago
- Fashion Value Chain
Sold Out on Day One: India Can't Get Enough of McDonald's New ‘Protein Plus Slice'
McDonalds India (West & South), operated by Westlife Foodworld, witnessed unprecedented demand following the launch of its innovative Protein Plus Slice, with multiple outlets selling out of the new item on the very first day. The brand served more than 32,000 slices within 24 hours of launch, delivering approximately 160,000 grams of plant-based protein to customers across West and South India. Hon'ble FDA Min of Maharashtra, Shri Yogesh Kadam, Director – CSIR-CFTRI, along with the CEO and the MD of Westlife Foodworld at the launch event of McDonalds Protein Plus Slice The response was immediate and overwhelming, with customers eagerly customizing their favorite burgers with the protein enhancement. Mumbai led the region with over 11,000 slices sold, while Pune and Ahmedabad each surpassed 3,000 slices. Strong performance was also observed in Bengaluru and Chennai, with each exceeding 1,500 slices. The New Protein Plus Slice co-developed by CSIR-CFTRI The newly launched Protein Plus Range, features a first-of-its-kind 100% vegetarian, plant-based protein slice that adds 5 grams of protein to any burger. For the first time in the QSR industry, McDonalds is revolutionizing how people eat by allowing customers to add one, two, or even three slices to their favourite burgers, empowering them with greater nutritional choice without compromising taste. The launch event was inaugurated by Shri Yogesh Kadam, Honble Minister of State for FDA, Government of Maharashtra, who emphasized the growing need for safer and nutritious food choices that meet the needs of todays consumers. Developed in collaboration with the prestigious CSIR-Central Food Technological Research Institute (CFTRI), under the Ministry of Science & Technology, Government of India, the Protein Plus Slice contains no artificial colours or flavours and is free from onion and garlic, making it suitable for a wide range of dietary preferences. Akshay Jatia, Chief Executive Officer, Westlife Foodworld said, 'At McDonald's India, we have always believed in giving our customers more choice, and this time, we are giving them the power to personalize their protein intake. The Protein Plus Range allows them to enjoy their favourite McDonald's burgers without compromising on their protein needs or the taste. It also reflects our ongoing commitment to our 'Real Food, Real Good' philosophy, bringing together flavour, nutrition, and food science. We are grateful to CSIR-CFTRI for partnering with us to bring this forward-thinking product to life. Together, we remain committed to crafting menu items that are both wholesome and delicious, combining locally available ingredients in a way where great taste and nutrition go hand in hand.' Dr. Sridevi Annapurna Singh, Director, CSIR-CFTRI said, 'Building on our earlier success with the Multi-Millet Bun, we are excited to continue our partnership with McDonald's India to advance nutritional innovation in the QSR space. The Protein Plus slice is an outcome of science-backed formulation and a shared vision to elevate everyday meals through nutrition. This partnership showcases how industry and scientific institutions can come together to bring meaningful nutritional upgrades to mainstream eating.' This remarkable market response reinforces McDonalds Indias commitment to its Real Food, Real Good philosophy and demonstrates the brands leadership in menu innovation that genuinely addresses evolving consumer preferences. Customers across West and South can now savour their favourite burgers with the added nutritional goodness of protein, whether dining in, picking up via Drive-Thru, or ordering from the comfort of their homes through the McDelivery app. For more infromation, please visit: